Philippines Diabetes Care Devices Market

What is the Philippines Diabetes Care Devices Market Size?

As per the survey report on Philippines diabetes care devices market, the market is expected to foresee a CAGR value of 7.6% during 2026-2036, and further generate a market size of USD 228.7 million by the end of 2036. In 2025, the market size was value at USD 85.6 million revenue.

• The Philippines diabetes care devices market’s growth is driven by rising prevalence of diabetes.
• KDMI analyst’s growth analysis foresees limited insurance coverage as restraint for Philippines diabetes care devices market.
• In the Philippines Diabetes Care Devices market, monitoring devices is the leading segment.

Philippines Diabetes Care Devices Market Analysis

Diabetes care devices are medical technologies designed to monitor, manage, and treat blood sugar levels for individuals suffering from diabetes. The devices range from glucose meters and insulin pumps to sensors. They improve glycemic control by providing real-time data or automating insulin delivery. The Philippines diabetes care devices market growth is driven by increasing incidence across the country, lifestyle changes, and rising obesity rates. In 2021, approximately 4.3 million people were diagnosed with diabetes, while 2.8 million were undiagnosed. The prevalence rate of diabetes in the country is more than 7.5% with 4 lakh+ active cases. Furthermore, significant advancement in medical technology and increasing penetration of smartphone is further accelerating market growth. Also, increasing focus on preventive care and early detection is strengthening demand for advanced devices.

Philippines Diabetes Care Devices Market Growth Drivers and Restraints

Growth Drivers

• Rising prevalence of diabetes – The growing incidence of diabetes across Philippines is a key driver for the advanced devices, as lifestyle changes such as increased consumption of processed foods, reduced physical activity, and rising obesity levels continue to increase in number of diabetic patients. According to the UNICEF report, 1 in 10 children and approximately 4 in 10 adults in the Philippines are classified as overweight and obese. Since diabetes is a lifelong condition, patients depend heavily on devices like blood glucose meters, continuous glucose monitoring (CGM) systems, and insulin delivery tools for daily care. The rising prevalence is also leading to increased cases of complications such as cardiovascular diseases, neuropathy, and kidney disorders, further reinforcing the importance of regular glucose tracking and timely intervention. This sustained and growing demand for effective disease management solutions is directly accelerating the adoption of diabetes care devices across both urban and semi-urban populations.
• Expansion of digital health and telemedicine – The rapid growth of digital health ecosystem and telemedicine platforms in the Philippines is significant transforming diabetes management by improving accessibility, convenience, and continuity of care. According to the PMC data, nearly 70 percent of healthcare facilities have adopted EHR, covering almost 60% of Philippine population. With increasing internet penetration and smartphone usage, patients are now able to connect their diabetes care devices to mobile applications that enable real-time glucose monitoring, data sharing, and remote consultations with healthcare professionals. Telemedicine reduces the need for frequent hospital visits while allowing doctors to monitor patient data and adjust treatment plans proactively. Additionally, the integration of cloud-based analytics and AI-driven insights is enhancing personalized care and early detection of complications, thereby driving overall market expansion for advanced diabetes devices.

Restraints

• Limited healthcare infrastructure in rural areas – The key restraint is the strong demand for advanced healthcare in rural and remote areas. Limited availability of infrastructure facilities restricts access to advanced care devices. Further, lack of proper facilities and trained professionals impact market overall growth.
• Limited insurance coverage – Another restraint is the inadequate insurance reimbursement for diabetes devices that makes them less accessible to a large base of the population. This requires many patients to pay out-of-pocket, which discourages cost-sensitive population to adopt advanced diabetes care devices, thereby limiting market value share.

Philippines Diabetes Care Devices Market Segmentation

Our experts at KD Market Insights have segmented the Philippines diabetes care devices market research report as:

Philippines Diabetes Care Devices Market Competitive Landscape

Some of the significant participants who top the Philippines diabetes care devices market growth:

• Abbott Laboratories
• Dexcom Inc.
• Medtronic plc
• F. Hoffmann-La Roche Ltd.
• Insulet Corporation
• Novo Nordisk A/S
• Tandem Diabetes Care Inc.
• Becton, Dickinson and Company
• Ypsomed AG
• Ascensia Diabetes Care